Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its hematology pipeline will be shared across 23 abstracts at the American Society of Hematology (ASH) 2024 ...
Our Hematology & Hematologic Malignancies team provides advanced care for non-cancerous (benign), blood-related illnesses. Typically these are diseases that involve red blood cells, white blood cells, ...
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations business unit, designed to integrate disease expertise ...
Sankaran is in the Division of Hematology and Oncology at Boston ... an inherited disorder that affects red blood cells; Wiskott–Aldrich syndrome (WAS), a deficiency in immune cells; and ...
Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session – – Tebapivat Phase 1 Data in Sickle Cell Disease and Phase 2b ...